Screener
Quince Therapeutics, Inc. QNCX Q1 2026 Annual earnings
Reported May 11, 2026 · Before market open
EPS-$0.59Beat by $0.71
EPS estimate-$1.30
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$4.03
Versus estimates
Diluted EPS
FAQ
- When did Quince Therapeutics, Inc. report Q1 2026 earnings?
- Quince Therapeutics, Inc. (QNCX) reported Q1 2026 earnings on May 11, 2026 before market open.
- What were Quince Therapeutics, Inc.'s Q1 2026 revenue and EPS?
- Quince Therapeutics, Inc. reported eps of $-0.59 for Q1 2026.
- Did Quince Therapeutics, Inc. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-1.30 by $0.71.
- How did Quince Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 73.5% from $-0.34.
- Where can I find Quince Therapeutics, Inc.'s Q1 2026 SEC filings?
- You can read the 10-K periodic report (0001193125-26-151364) directly on SEC EDGAR. The filing index links above go to sec.gov.
